News & Media

Newsroom

SK Biopharmaceuticals to Launch JV with Eurofarma in US for AI Digital Health Solutions

06.18.2025

SK Biopharmaceuticals Signs MOU with PhnyX Lab to Advance AI-Powered DrugDevelopment

6.18.2025

SK Life Science Launches Its Second National Ad, Continuing to Lead with the Only Direct-toConsumer Commercial for an Anti-Seizure Drug in the U.S.

5.19.2025

SK Life Science, Inc. to Showcase Important XCOPRI® (cenobamate tablets) CV Data on Responsive Neurostimulation Epileptiform Events at the 77th American

04.04.2025

Newly Published Epilepsia Supplement Highlights Potential of Third Generation Antiseizure Medications to Help More Patients Achieve Seizure Freedom

3.20.2025

Welcome to the news and information center for SK Life Science, Inc.

To learn more about SK Life Science, please download our corporate brochure

For more information about epilepsy, please download this infographic

For more information about Lennox-Gastaut syndrome, please download this fact sheet

X Community Guidelines

LinkedIn Community Guidelines

Bluesky Community Guidelines

Youtube Community Guidelines

Facebook Community Guidelines

SK Life Science at a Glance

Headquarters Location: Paramus, NJ

R&D Begins: 1993

Parent Company: SK Life Science is a subsidiary of SK Biopharmaceuticals, CO., LTD, and both are a part of SK Group

Number of Employees: 200+ Employees

Disease Category Focus: CNS Disorders and Oncology

Pipeline: 8 compounds under clinical development

Top